DAGMAWIT BEHAILU: Open Payments
NPI 1962121244 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 42 payments from 12 companies in 2025. Trend: 2023 $543 · 2024 $765 · 2025 $1,269
Food & beverage: $1,086Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $207 |
| Madrigal Pharmaceuticals | 2 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $166 |
| ABBVIE INC. | 7 | $155 |
| Regeneron Healthcare Solutions, Inc. | 3 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $138 |
| PFIZER INC. | 5 | $104 |
| QOL Medical, LLC | 2 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Ardelyx, Inc. | 1 | $27 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, ENTYVIO, Sucraid, VELSIPITY, RINVOQ, DUPIXENT.
Industry payments across VA — which companies pay providers there.
